Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | methionine aminopeptidase, putative | 0.0231 | 0.5026 | 0.5 |
Leishmania major | methionine aminopeptidase, putative,metallo-peptidase, Clan MG, Family M24 | 0.0231 | 0.5026 | 0.5 |
Trypanosoma cruzi | metallo- peptidase, Clan MG, Family M24 | 0.0231 | 0.5026 | 0.5 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapB (map) (peptidase M) | 0.0146 | 0 | 0.5 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapA (map) (peptidase M) (MetAP) | 0.0146 | 0 | 0.5 |
Trypanosoma cruzi | metallo- peptidase, Clan MG, Family M24 | 0.0231 | 0.5026 | 0.5 |
Plasmodium falciparum | methionine aminopeptidase 1b, putative | 0.0231 | 0.5026 | 1 |
Trypanosoma brucei | metallo- peptidase, Clan MG, Family M24 | 0.0231 | 0.5026 | 0.5 |
Mycobacterium ulcerans | methionine aminopeptidase MapB | 0.0146 | 0 | 0.5 |
Treponema pallidum | methionine aminopeptidase (map) | 0.0146 | 0 | 0.5 |
Mycobacterium ulcerans | methionine aminopeptidase | 0.0146 | 0 | 0.5 |
Chlamydia trachomatis | methionine aminopeptidase | 0.0146 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPB (MAP) (PEPTIDASE M) | 0.0146 | 0 | 0.5 |
Loa Loa (eye worm) | methionine aminopeptidase type I | 0.0231 | 0.5026 | 0.5 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0315 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | methionine aminopeptidase | 0.0146 | 0 | 0.5 |
Brugia malayi | Methionine aminopeptidase protein type I | 0.0231 | 0.5026 | 0.5 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0315 | 1 | 1 |
Echinococcus multilocularis | methionyl aminopeptidase 1 (M24 family) | 0.0231 | 0.5026 | 0.5026 |
Plasmodium vivax | methionine aminopeptidase 1b, putative | 0.0231 | 0.5026 | 1 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPA (MAP) (PEPTIDASE M) (MetAP) | 0.0146 | 0 | 0.5 |
Toxoplasma gondii | methionine aminopeptidase | 0.0231 | 0.5026 | 1 |
Trypanosoma brucei | methionine aminopeptidase, type I, putative | 0.0231 | 0.5026 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.